Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (28660)	4/6/1999 2:27:00 PM
From: RXGOLF	Read Replies (1) \| Respond to of 32384

<<"how many patients come into your pharmacy who have KS?">> I don't have access to the diagnosis of our customers. My guess would be, very few. We have geared our entire practice to acute care, due to our proximity of less than 1/4 a mile to the two largest acute care clinics in a 70 mile radius. Being the closest practice to each of these clinics, we specialize in being the fastest provider in our area due to the type of patient we try to serve. We stock zero drugs that are used in the treatment of the HIV virus(ie:protease inhibitors,non-nucleoside reverse transcriptase inhibitors,etc), and therefore I base my guess on these facts. Am I wrong in assuming you ask this question in a way to underline the fact that relatively few individuals will be treated for KS?